Glucuronidation versus oxidation of the flavonoid galangin by human liver microsomes and hepatocytes

被引:108
作者
Otake, Y
Hsieh, F
Walle, T
机构
[1] Med Univ S Carolina, Dept Cell & Mol Pharmacol & Expt Therapeut, Charleston, SC 29425 USA
[2] Amgen Inc, Thousand Oaks, CA 91320 USA
关键词
D O I
10.1124/dmd.30.5.576
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In a previous study, we used human liver microsomes for the first time to study cytochrome P450 (P450)-mediated oxidation of the flavonoid galangin. The combination of CYP1A2 and CYP2C9 produced a V-max/K-m value of 13.6 +/- 1.1 mul/min/mg of protein. In the present extended study, we determined glucuronidation rates for galangin with the same microsomes. Two major and one minor glucuronide were identified by liquid chromatography/mass spectrometry. The V-max/K-m values for the two major glucuronides conjugated in the 7- and 3-positions were 155 +/- 30 and 427 +/- 26 mul/min/mg of protein, thus, exceeding that of oxidation by 11 and 31 times, respectively. This highly efficient glucuronidation appeared to be catalyzed mainly by the UDP-glucuronosyltransferase (UGT)1A9 isoform but also by UGT1A1 and UGT2B15. Sulfation of galangin by the human liver cytosol, mediated mainly but not exclusively by sulfotransferase (SULT) 1A1, also appeared to be efficient. These conclusions were strongly supported by experiments using the S9 fraction of the human liver, in which all three metabolic pathways could be directly compared. When galangin metabolism was examined in fresh plated hepatocytes from six donors, glucuronidation clearly predominated followed by sulfation. Oxidation occurred only to a minor extent in two of the donors. This study for the first time establishes that glucuronidation and sulfation of galangin, and maybe other flavonoids, are more efficient than P450-mediated oxidation, clearly being the metabolic pathways of choice in intact cells and therefore likely also in vivo.
引用
收藏
页码:576 / 581
页数:6
相关论文
共 35 条
[21]   Quercetin is recovered in human plasma as conjugated derivatives which retain antioxidant properties [J].
Manach, C ;
Morand, C ;
Crespy, V ;
Demigné, C ;
Texier, O ;
Régérat, F ;
Rémésy, C .
FEBS LETTERS, 1998, 426 (03) :331-336
[22]   The use of adult human hepatocytes in primary culture and other in vitro systems to investigate drug metabolism in man [J].
Maurel, P .
ADVANCED DRUG DELIVERY REVIEWS, 1996, 22 (1-2) :105-132
[23]   TOLBUTAMIDE HYDROXYLATION BY HUMAN-LIVER MICROSOMES - KINETIC CHARACTERIZATION AND RELATIONSHIP TO OTHER CYTOCHROME-P-450 DEPENDENT XENOBIOTIC OXIDATIONS [J].
MINERS, JO ;
SMITH, KJ ;
ROBSON, RA ;
MCMANUS, ME ;
VERONESE, ME ;
BIRKETT, DJ .
BIOCHEMICAL PHARMACOLOGY, 1988, 37 (06) :1137-1144
[24]   Oxidation of the flavonoids galangin and kaempferide by human liver microsomes and CYP1A1, CYP1A2, and CYP2C9 [J].
Otake, Y ;
Walle, T .
DRUG METABOLISM AND DISPOSITION, 2002, 30 (02) :103-105
[25]  
Ren Q, 2000, DRUG METAB DISPOS, V28, P1352
[26]  
Rodrigues AD, 1997, DRUG METAB DISPOS, V25, P1097
[27]  
SHIMAMURA H, 1993, BIOL PHARM BULL, V16, P899
[28]  
Soars MG, 2001, DRUG METAB DISPOS, V29, P121
[29]   Genetic multiplicity of the human UDP-glucuronosyltransferases and regulation in the gastrointestinal tract [J].
Tukey, RH ;
Strassburg, CP .
MOLECULAR PHARMACOLOGY, 2001, 59 (03) :405-414
[30]   ENZYMATIC ASSAY FOR FLAVONOID SULFOTRANSFERASE [J].
VARIN, L ;
BARRON, D ;
IBRAHIM, RK .
ANALYTICAL BIOCHEMISTRY, 1987, 161 (01) :176-180